No-Flush Niacin
60/100
Review before taking
- Niacin: 430mg is 12.3× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 430mg is 12.3× the Tolerable Upper Intake Level (35mg)
This supplement contains a dose of niacin that is more than 12 times the recommended maximum daily limit.
Label Data
1 Capsule(s)
Serving Size
75
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
430 mg
(2688% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 12.3× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Hydroxypropyl Methylcellulose
Microcrystalline Cellulose
L-Leucine
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested use As a dietary supplement, 1 capsule two or three times daily with meals, or as directed by a healthcare practitioner.
⚠️ Warnings & Precautions
Do not take large amounts of Niacin (greater than 1.5 grams per day) without first consulting a healthcare practitioner.
🧪 Formulation Notes
Provides inositol hexanicotinate. Taken orally, the niacin releases slowly, thereby minimizing the likelihood of "niacin flush". Though chemically linked to inositol, the niacin in this formulation is highly bio-available.
Inositol Hexanicotinate
Hypoallergenic
Additional Information
Keep in a cool, dry place, tightly capped.
Product Details
UPC / SKU
7 13947 70370 4
DSLD Entry Date
2020-08-23
Product Type
Vitamin
Form
Capsule
Brand
Allergy Research Group
DSLD ID
233222
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100